Immagine di testata Immagine di testata

PROGRAMME

Download the full programme

Wednesday, March 19th 2025

9 - 10.30 a.m. Session 5 - RNA technologies for therapy development Anfiteatro
Chairs: Marco Sandri, Laura Cancedda
Plenary talks
A new RNA-based therapy for the Fragile X Syndrome
Claudia Bagni, University of Rome "Tor Vergata"
mRNA-replacement therapy for Glycogen Storage Disease type 1b
Lucia De Stefano, Telethon Institute of Genetic and Medicine (Pozzuoli)
Developing a strategy to target AR coactivators in preclinical models of SBMA
Manuela Basso, University of Trento
PRODOTTI GIANNI – sponsored flash talk
New Generation Drug Delivery Systems: intracellular uptake and trafficking studies
Barbara Canonico, Professor at University of Urbino Carlo Bo
Flash presentations
  • Alessia Oppezzo, IFOM ETS (Milan) - Selective control of DNA damage response at telomeres as an innovative therapeutic approach for Dyskeratosis Congenita
  • Roberta Benfante, National Research Council (Milan) - The natural antisense lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
  • Roberto Oleari, University of Milan - Combining spatial and gene transcriptomics to reveal NKTR as nuclear splicing protein implicated in head development and in a novel spliceosomopathy
  • Dalila Capasso, Telethon Institute of Genetic and Medicine (Pozzuoli) - Gaining insight into the role of noncoding RNAs in Inherited Retinal Disease by RNA-seq-based approaches
10.30 - 11.30 a.m. Coffee break Sala della Piazza
with take-away
11.30 - 12.45 p.m. Session 6 - Innovative therapeutic approaches Anfiteatro
Chairs: Maria Pennuto, Emiliano Biasini
Plenary talks
A membrane-targeted photoswitch restores physiological ON/OFF responses to light in the degenerate retina
Fabio Benfenati, Italian Institute of Technology (Genova)
A Pipeline for drug discovery in Lowe Syndrome
Antonella De Matteis, Telethon Institute of Genetics and Medicine (Naples)
Classification and rescue of HCN1 mutations in EIEE patients
Anna Moroni, University of Milan
Flash presentations
  • Francesco Gentile, Università Vita-Salute San Raffaele (Milan) - Genetic and pharmacologic modulation of the ATF6 UPR-related pathway affect disease pathogenesis in mice models of CMT1B
  • Angela Della Sala, University of Torino - Rescue of Mutant CFTR Chloride Channels by a Mimetic Peptide Targeting the A-Kinase Anchoring Function of PI3Kγ
  • Sandro Montefusco, Telethon Institute of Genetics and Medicine (Pozzuoli) - Combining phenotypic high-content imaging with the repurposing of drugs to tackle lysosomal storage disorders
  • Enrica Federti, University of Verona - Resolvin D1 protects against sickle cell related inflammatory cardiomyopathy in humanized mice
  • Nicole Innocenti, University of Trento - Targeting the undruggable: chemical exploration of a prion protein degrader compound
12.45 - 13.25 p.m. Late Breaking News Anfiteatro
13.25 - 13.30 p.m. Closing Anfiteatro